trending Market Intelligence /marketintelligence/en/news-insights/trending/7-Hv-U_V8LcV24dzNtxnwQ2 content esgSubNav
In This List

CytoSorbents names chief medical officer

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


CytoSorbents names chief medical officer

Eric Mortensen will become Cytosorbents Corp.'s chief medical officer on June 1, succeeding Robert Bartlett, who is retiring.

Bartlett will continue working with the company as a consultant and as co-chair of the cardiac surgery advisory board with Joseph Zwischenberger.

Mortensen is the former vice president and therapeutic area clinical head for inflammation and immunology at Pfizer Inc.